Rxo Inc (NYSE:RXO) Receives $17.08 Average Price Target from Analysts

Rxo Inc (NYSE:RXOGet Free Report) has earned a consensus rating of “Hold” from the seventeen analysts that are covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and three have given a buy rating to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $17.2308.

A number of research analysts recently commented on the stock. Wall Street Zen upgraded shares of RXO from a “sell” rating to a “hold” rating in a research note on Saturday, August 9th. Stifel Nicolaus increased their target price on shares of RXO from $14.00 to $17.00 and gave the stock a “hold” rating in a research report on Friday. Barclays decreased their target price on shares of RXO from $18.00 to $17.00 and set an “overweight” rating on the stock in a research report on Tuesday, August 12th. Cowen restated a “hold” rating on shares of RXO in a research report on Friday, August 8th. Finally, Morgan Stanley decreased their target price on shares of RXO from $23.00 to $21.00 and set an “equal weight” rating on the stock in a research report on Monday, July 7th.

Get Our Latest Report on RXO

RXO Stock Down 1.3%

Shares of RXO opened at $16.38 on Tuesday. RXO has a 52 week low of $12.19 and a 52 week high of $31.98. The firm has a market cap of $2.69 billion, a P/E ratio of -7.58, a price-to-earnings-growth ratio of 8.60 and a beta of 1.65. The firm’s 50-day simple moving average is $16.06 and its 200 day simple moving average is $15.71. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.35 and a current ratio of 1.35.

RXO (NYSE:RXOGet Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.04 EPS for the quarter, beating analysts’ consensus estimates of $0.02 by $0.02. RXO had a negative net margin of 5.45% and a positive return on equity of 1.18%. The business had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.44 billion. During the same quarter in the prior year, the business earned $0.03 EPS. RXO’s quarterly revenue was up 52.6% on a year-over-year basis. On average, analysts forecast that RXO will post 0.31 earnings per share for the current year.

Institutional Trading of RXO

Several large investors have recently made changes to their positions in the company. Douglas Lane & Associates LLC boosted its position in shares of RXO by 3.4% during the 3rd quarter. Douglas Lane & Associates LLC now owns 3,866,005 shares of the company’s stock worth $59,459,000 after acquiring an additional 126,227 shares in the last quarter. Osaic Holdings Inc. lifted its stake in RXO by 101.6% in the 2nd quarter. Osaic Holdings Inc. now owns 8,507 shares of the company’s stock valued at $134,000 after purchasing an additional 4,287 shares during the last quarter. Squarepoint Ops LLC lifted its stake in RXO by 304.8% in the 2nd quarter. Squarepoint Ops LLC now owns 171,620 shares of the company’s stock valued at $2,698,000 after purchasing an additional 129,228 shares during the last quarter. Thrivent Financial for Lutherans lifted its stake in RXO by 1.0% in the 2nd quarter. Thrivent Financial for Lutherans now owns 104,861 shares of the company’s stock valued at $1,648,000 after purchasing an additional 1,007 shares during the last quarter. Finally, Neuberger Berman Group LLC bought a new position in RXO in the 2nd quarter valued at approximately $170,000. Institutional investors and hedge funds own 92.73% of the company’s stock.

RXO Company Profile

(Get Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Recommended Stories

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.